Despite a dip in net sales, Ascent Industries Co reports improved gross profit and reduced net loss, alongside strategic share repurchases and operational enhancements.
Despite a revenue dip, Seer Inc outlines strategic initiatives and a $25 million share repurchase program to bolster long-term growth.
Discover how Mirum Pharmaceuticals achieved a 137% increase in sales and navigated significant operational hurdles in the first quarter of 2024.